Skip to main content
Premium Trial:

Request an Annual Quote

Mission Bio: Tapestri Solution for Solid Tumor Research

Mission Bio has launched the Tapestri Solution for Solid Tumor Research.

This single-cell DNA sequencing workflow for Mission Bio's Tapestri platform includes a nuclei isolation prep protocol, pre-designed research panels for breast cancer and glioblastoma multiforme, and an improved single-cell copy number variation (CNV) bioinformatic analysis tool. The new solid tumor workflow adds to the company's existing workflow for hematological cancers. 

Tapestri measures DNA alterations at the individual cell level in thousands of cells at a time, co-detecting single nucleotide variations, indels, and CNVs, definitively identifying variant zygosity and mutational co-occurrence, and detecting rare cell populations, the company said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.